These effects are mediated by the upregulation of PPAR-γ, a transcription factor that regulates adipocyte differentiation, glucose homeostasis, and inflammation, ultimately leading to reduced insulin resistance and lower risk of type 2 diabetes [17, 18, 29]. Here, PPARG is linked to type 2 diabetes mellitus.